In randomized managed trials, There are 2 treatment possibilities currently considered the normal of care in Guillain-Barré syndrome (GBS). These incorporate possibly intravenous immunoglobulin (IVIG) or plasma Trade. https://ksnr.org.in/guillain-barre-syndrome/